MA38588B1 - Dérivés bi-aromatiques antibactériens - Google Patents
Dérivés bi-aromatiques antibactériensInfo
- Publication number
- MA38588B1 MA38588B1 MA38588A MA38588A MA38588B1 MA 38588 B1 MA38588 B1 MA 38588B1 MA 38588 A MA38588 A MA 38588A MA 38588 A MA38588 A MA 38588A MA 38588 B1 MA38588 B1 MA 38588B1
- Authority
- MA
- Morocco
- Prior art keywords
- hydroxy
- alkoxy
- cyano
- dashed line
- oxoethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention porte sur des composés antibactériens de formule i i dans laquelle r est h, un groupe cyano, alcoxy, cyanométhoxy, cycloalkylméthoxy, hydroxyalcoxy, alcoxyalcoxy, alcoxycarbonyle, 2-éthoxy-2-oxoéthoxy, 2-(méthylamino)-2-oxoéthoxy, (1-cyanocyclobutyl)méthoxy, 3-hydroxy-pyrrolidin-1-yle ou 3,4-dihydroxycyclopentyl)méthoxy; u1 est n ou cr1, u2 est n ou cr2, u3 est n ou cr3 et u4 est n ou cr4, étant entendu qu'au plus trois de u1, u2, u3 et u4 peuvent être n en même temps; v1 est n ou cr5, v2 est n ou cr6, v3 est n ou cr7 et v4 est n ou ch, étant entendu qu'au plus deux de v1, v2, v3 et v4 peuvent être n en même temps; r1 est h, un groupe cyano, hydroxy ou alcoxy; r2 est h, un groupe hydroxy ou alcoxy; r3 est h, un groupe cyano, hydroxy, alcoxy ou carboxamido; r4 est h ou un groupe alcoxy; r5 est h ou un groupe hydroxy ou halogéno; r6 est h ou un groupe hydroxy ou halogéno; r7 est h; la ligne en tirets " " représente une liaison ou est absente; w représente ch ou n quand la ligne en tirets " " est une liaison, ou w représente ch2 quand la ligne en tirets " " est absente; x représente ch ou n; et q représente o ou s; et leurs sels.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2013053021 | 2013-04-16 | ||
PCT/IB2014/060724 WO2014170821A1 (fr) | 2013-04-16 | 2014-04-15 | Dérivés bi-aromatiques antibactériens |
Publications (2)
Publication Number | Publication Date |
---|---|
MA38588A1 MA38588A1 (fr) | 2017-05-31 |
MA38588B1 true MA38588B1 (fr) | 2018-04-30 |
Family
ID=50639826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38588A MA38588B1 (fr) | 2013-04-16 | 2014-04-15 | Dérivés bi-aromatiques antibactériens |
Country Status (21)
Country | Link |
---|---|
US (1) | US9527867B2 (fr) |
EP (1) | EP2986607B1 (fr) |
JP (1) | JP6375365B2 (fr) |
KR (1) | KR20150143720A (fr) |
CN (1) | CN105143216B (fr) |
AR (1) | AR095884A1 (fr) |
AU (1) | AU2014255326B2 (fr) |
BR (1) | BR112015026261A8 (fr) |
CA (1) | CA2907832A1 (fr) |
CL (1) | CL2015003019A1 (fr) |
EA (1) | EA029361B1 (fr) |
ES (1) | ES2640482T3 (fr) |
HK (1) | HK1221459A1 (fr) |
MA (1) | MA38588B1 (fr) |
MX (1) | MX362338B (fr) |
PH (1) | PH12015502411A1 (fr) |
PL (1) | PL2986607T3 (fr) |
SA (1) | SA515361261B1 (fr) |
SG (1) | SG11201508479RA (fr) |
TW (1) | TWI631119B (fr) |
WO (1) | WO2014170821A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR073774A1 (es) | 2008-10-07 | 2010-12-01 | Actelion Pharmaceuticals Ltd | Compuestos antibioticos oxazolidinona triciclicos |
AR102256A1 (es) * | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
TW201722965A (zh) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
TW201808906A (zh) | 2016-03-16 | 2018-03-16 | 拜耳作物科學股份有限公司 | 作為殺蟲劑之經取代吡啶化合物 |
AR108108A1 (es) | 2016-04-14 | 2018-07-18 | Idorsia Pharmaceuticals Ltd | Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi |
GB2550437B (en) * | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
TW201833120A (zh) * | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
EP3284739A1 (fr) | 2017-07-19 | 2018-02-21 | Bayer CropScience Aktiengesellschaft | Composés (hét)aryl substitués comme produit de lutte contre les parasites |
EP3717490B1 (fr) | 2017-11-29 | 2023-05-24 | Bugworks Research, Inc. | Composés hétérocycliques antibactériens et leurs synthèses |
MA53219A (fr) | 2018-08-13 | 2021-11-17 | Hoffmann La Roche | Nouveaux composés hétérocycliques en tant qu'inhibiteurs de monoacylglycérol lipase |
MX2022002311A (es) | 2019-09-12 | 2022-03-25 | Hoffmann La Roche | Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de monoacilglicerol lipasa (magl). |
CN115298176A (zh) * | 2020-03-24 | 2022-11-04 | 豪夫迈·罗氏有限公司 | 化合物以及它们在治疗细菌感染中的用途 |
CN115785718B (zh) * | 2022-11-25 | 2023-08-22 | 四川大学 | 一种多基底表面的金属配位抗菌涂层及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0297042A1 (fr) | 1987-06-23 | 1988-12-28 | Ciba-Geigy Ag | Dérivés de pénème substitués |
DE19802239A1 (de) | 1998-01-22 | 1999-07-29 | Bayer Ag | Neue mit Bicyclen substituierte Oxazolidinone |
WO2001030782A2 (fr) | 1999-10-29 | 2001-05-03 | Syngenta Participations Ag | Nouveaux herbicides |
AU2002347985A1 (en) | 2001-11-15 | 2003-06-10 | Eli Lilly And Company | Peroxisome proliferator activated receptor alpha agonists |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
WO2006102674A2 (fr) | 2005-03-24 | 2006-09-28 | Microbia, Inc. | Inhibiteurs d'absorption de cholesterol de diphenylheterocycle |
TW200734311A (en) | 2005-11-21 | 2007-09-16 | Astrazeneca Ab | New compounds |
EP2141154A4 (fr) | 2007-03-30 | 2011-06-01 | Inst Med Molecular Design Inc | Dérivé d'oxazolidinone ayant une activité inhibitrice sur la 11 -hydroxystéroïde déshydrogénase de type i |
CL2008001003A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
NZ586013A (en) | 2007-12-20 | 2012-02-24 | Pharma Mar Sa | Antitumoral compounds |
JP5349500B2 (ja) | 2008-02-20 | 2013-11-20 | アクテリオン ファーマシューティカルズ リミテッド | アザトリシクリック抗菌性化合物 |
CA2713187C (fr) | 2008-02-22 | 2016-06-07 | Actelion Pharmaceuticals Ltd | Derives d'oxazolidinone |
MX2011000968A (es) * | 2008-08-04 | 2011-03-02 | Actelion Pharmaceuticals Ltd | Derivados de alquilaminometiloxazolidinona triciclicos. |
AR073774A1 (es) | 2008-10-07 | 2010-12-01 | Actelion Pharmaceuticals Ltd | Compuestos antibioticos oxazolidinona triciclicos |
EP2346862B1 (fr) * | 2008-10-10 | 2012-09-12 | Actelion Pharmaceuticals Ltd. | 2-benzothiophényl- et 2-naphtyl-oxazolidinones et leurs analogues isostères aza utilisés comme agents antibactériens |
CA2854264A1 (fr) | 2011-11-08 | 2013-05-16 | Actelion Pharmaceuticals Ltd | Derives antibiotiques de 2-oxo-oxazolidin-3,5-diyle |
-
2014
- 2014-04-15 AU AU2014255326A patent/AU2014255326B2/en not_active Ceased
- 2014-04-15 JP JP2016508263A patent/JP6375365B2/ja not_active Expired - Fee Related
- 2014-04-15 EP EP14721539.6A patent/EP2986607B1/fr not_active Not-in-force
- 2014-04-15 CN CN201480022059.9A patent/CN105143216B/zh not_active Expired - Fee Related
- 2014-04-15 CA CA2907832A patent/CA2907832A1/fr not_active Abandoned
- 2014-04-15 BR BR112015026261A patent/BR112015026261A8/pt not_active Application Discontinuation
- 2014-04-15 TW TW103113729A patent/TWI631119B/zh not_active IP Right Cessation
- 2014-04-15 EA EA201501025A patent/EA029361B1/ru not_active IP Right Cessation
- 2014-04-15 US US14/784,602 patent/US9527867B2/en active Active
- 2014-04-15 ES ES14721539.6T patent/ES2640482T3/es active Active
- 2014-04-15 SG SG11201508479RA patent/SG11201508479RA/en unknown
- 2014-04-15 WO PCT/IB2014/060724 patent/WO2014170821A1/fr active Application Filing
- 2014-04-15 PL PL14721539T patent/PL2986607T3/pl unknown
- 2014-04-15 KR KR1020157032552A patent/KR20150143720A/ko active IP Right Grant
- 2014-04-15 MX MX2015014576A patent/MX362338B/es active IP Right Grant
- 2014-04-15 MA MA38588A patent/MA38588B1/fr unknown
- 2014-04-16 AR ARP140101625A patent/AR095884A1/es unknown
-
2015
- 2015-10-04 SA SA515361261A patent/SA515361261B1/ar unknown
- 2015-10-09 CL CL2015003019A patent/CL2015003019A1/es unknown
- 2015-10-16 PH PH12015502411A patent/PH12015502411A1/en unknown
-
2016
- 2016-08-10 HK HK16109490.8A patent/HK1221459A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
SG11201508479RA (en) | 2015-11-27 |
BR112015026261A8 (pt) | 2017-12-26 |
SA515361261B1 (ar) | 2016-06-15 |
AU2014255326A1 (en) | 2015-11-26 |
CA2907832A1 (fr) | 2014-10-23 |
JP6375365B2 (ja) | 2018-08-15 |
JP2016516805A (ja) | 2016-06-09 |
AU2014255326B2 (en) | 2018-09-13 |
HK1221459A1 (zh) | 2017-06-02 |
US9527867B2 (en) | 2016-12-27 |
BR112015026261A2 (pt) | 2017-07-25 |
EP2986607B1 (fr) | 2017-06-14 |
MX2015014576A (es) | 2016-03-04 |
EA029361B1 (ru) | 2018-03-30 |
TWI631119B (zh) | 2018-08-01 |
EA201501025A1 (ru) | 2016-08-31 |
PL2986607T3 (pl) | 2017-11-30 |
CL2015003019A1 (es) | 2016-09-30 |
MX362338B (es) | 2019-01-11 |
ES2640482T3 (es) | 2017-11-03 |
AR095884A1 (es) | 2015-11-18 |
US20160075722A1 (en) | 2016-03-17 |
CN105143216B (zh) | 2018-04-13 |
KR20150143720A (ko) | 2015-12-23 |
TW201516043A (zh) | 2015-05-01 |
EP2986607A1 (fr) | 2016-02-24 |
WO2014170821A1 (fr) | 2014-10-23 |
MA38588A1 (fr) | 2017-05-31 |
PH12015502411A1 (en) | 2016-02-22 |
CN105143216A (zh) | 2015-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA38588A1 (fr) | Dérivés bi-aromatiques antibactériens | |
MA39189A1 (fr) | Dérivés de 1h-indazole et de 1h-indole antibactériens | |
LTPA2020531I1 (lt) | Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui | |
CY1120066T1 (el) | Ενωση κινολονης | |
AR054341A1 (es) | Combinaciones sinergicas de compuestos activos fungicidas | |
MA38540A1 (fr) | Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6 | |
HRP20110451T1 (hr) | Upotreba izotiocijanata kao sredstva protiv mieloma | |
RS53877B1 (en) | IZOKSAZOL-PYRIDINE DERIVATIVES | |
BR112014016328A2 (pt) | novo derivado de nicotinamida ou sal do mesmo | |
MA34964B1 (fr) | Dérivés de pipéridine pontés | |
MA32711B1 (fr) | Pyrrolidine-2-carboxamides substitues | |
RS52661B (en) | THERAPEUTIC MEANS | |
MA37142A3 (fr) | Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine | |
AR077413A1 (es) | Derivados piridin-4-ilo | |
MA31597B1 (fr) | Nouveaux herbicides | |
RS53679B1 (en) | FURAZANOBENZIMIDAZOLES AS PROGRAMS FOR THE TREATMENT OF NEOPLASTIC OR AUTOIMMUNE DISEASES | |
MA38192B1 (fr) | Dérivés d'indole carboxamide utilisés en tant qu'antagonistes du récepteur p2x7 | |
RS51644B (en) | UNITS AND PREPARATIONS AS CHANNEL INHIBITORS ACTIVATING PROSTHESES | |
BR112012027378A2 (pt) | composto pesticida e seu uso | |
TN2011000550A1 (fr) | Derives de cyclopenta[c] pyrrolyla lkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique | |
BR112012017188A8 (pt) | composto agonista de mglu2, sua composição farmacêutica e seu uso | |
AR065157A1 (es) | Compuestos de 6-bencil- 2,3,4,7-tetrahidro-indolo [2,3-c] quinolina | |
TN2010000025A1 (fr) | Derives de l'indol -2-one disubstitues en 3, leur preparation et leur application en therapeutique | |
MA35134B1 (fr) | Derives de pyrazolidinz-3-one | |
BR112012013861A2 (pt) | ibidores da cisteína protease |